Tuesday, April 25, 2017 1:03:53 AM
In the introduction, I learned that this LDN research Trust or else a doctor associated with them is trying to raise money to begin a 3 year LDN/Multiple Sclerosis trial. Dr. Jarred Younger is the doctor's name.
Here is a small write up about it in this group's newsletter:http://www.ldnresearchtrust.org/sites/default/files/May.pdf
I'm just wondering if this trial has already begun or not.
This is a non-profit group and I appreciate all the work they and their volunteers do.
I would hate for ENDV to compete with them. I wonder if they have any connection with ENDV at all. I would think they would be very aware of everything that is happening in the world having to do with LDN.
Anyway, I'm looking forward to reading the book which is evidently filled with testimonials of people who have been helped by taking LDN. She admits that LDN is NOT a miracle drug. It does not work for everybody. Hopefully by doing more research and clinical trials, it can be more accurately determined who would and would not be helped by the drug. Narrowing that down might be tricky, but worthwhile. Depending on the efficacy of the drug, that might be necessary in order to get a high enough response rate that would induce the FDA to give approval. But it looks like the response rate was high enough in Kenya(or was it Nigeria) to get approval so that is encouraging!
I was surprised to hear about the proposed trial and so I thought I would ask to see if anyone knows any more about it. Back in June 2015, they refer to it as an "upcoming trial."
Thanks.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM